Icardio
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Automates ultrasound with artificial intelligence, holds FDA 510(k) clearance and Breakthrough Device Designation for CardioVision™, leverages a vast database of 200M+ echocardiogram images, and claims superior accuracy to humans for certain predictions like abnormal left ventricular function. Designed for integration with existing PACS and hardware, including for edge devices and sub-par imaging conditions.
Description Brand's website · 2026-10-04
iCardio.ai automates ultrasound interpretation, specifically for echocardiography, using artificial intelligence. It provides solutions for automated measurements, detection of structural heart diseases like Aortic Stenosis (with FDA clearance), image quality assessment, and comprehensive echo reports, partnering with ultrasound companies and integrating with PACS systems.
Offerings
Core capabilities Brand's website · 2026-10-04
- EchoMeasure™ (automated echo measurements)
- CardioVision™ (automated aortic stenosis detection with FDA clearance)
- EchoCheck (image quality and completeness tracking)
- Quantitative (automated linear and volumetric measurements)
- Qualitative (structural heart disease detection). Offers custom automated solutions and data for clinical validation.
Pricing Brand's website · 2026-10-04
Not explicitly stated, but implied to be B2B integration and custom solutions, likely subscription or project-based.
Audience
Target industry Brand's website · 2026-10-04
Ultrasound companies, clinicians, enterprises (PACS and hardware manufacturers), and institutions seeking to automate and improve echocardiogram interpretation.
Is this your business?
The information above is publicly sourced — assembled by Optimly from Icardio's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for Icardio across the index.
Claim Icardio — free →Page last updated 2026-10-17.